Prenetics Global Limited
Last updated September 27, 2026
Organization details
- Legal name
- Prenetics Global Limited
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Quarry Bay
- Headquarters country
- Hong Kong
- Fiscal year end
- December
- Ticker symbol
- PRE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001876431
Board of directors
-
Caroline S. Levy · DirectorSince 2026
-
Danny Sheng Wu Yeung · Director · Chief Executive OfficerSince 2026
-
Darshan Ravindra Shah · DirectorSince 2026
-
David Vanderveen · DirectorSince 2026
-
Hudson Blake Leogrande · DirectorSince 2026
-
Yin Pan Cheng · DirectorSince 2026
Chief executives
Danny Sheng Wu Yeung
· Chief Executive Officer
Since March 2026
Board connections
1 of this board's directors also sit on 1 other board.
- via Caroline S. Levy
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $999,698
- 5 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,000 | — | — |
| Aug 25, 2026 | Rosin Brian J Officer (CFO of IM8 (US) LLC) | Open-market purchase | +5,100 | $22.80 | $116,280 |
| Aug 24, 2026 | Rosin Brian J Officer (CFO of IM8 (US) LLC) | Open-market purchase | +18,000 | $21.19 | $381,420 |
| Aug 24, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Open-market purchase | +6,000 | $20.90 | $125,400 |
| Aug 24, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Open-market purchase | +11,181 | $21.40 | $239,273 |
| Aug 21, 2026 | Lo Hoi Chun Officer (Chief Financial Officer) | Option exercise | +32,736 | $0.00 | $3 |
| Aug 21, 2026 | Lo Hoi Chun Officer (Chief Financial Officer) | Option exercise | +45,815 | — | — |
| Aug 20, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Option exercise | +53,953 | $0.00 | $5 |
| Aug 20, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Other | −49,912 | — | — |
| Aug 20, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Open-market purchase | +7,500 | $18.31 | $137,325 |
| Aug 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,001 | — | — |
| Jul 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,000 | — | — |
| Jun 15, 2026 | Yin Pan Cheng Director | Option exercise | +15,873 | — | — |
| Jun 15, 2026 | David Vanderveen Director | Option exercise | +6,944 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.